BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 6447433)

  • 1. Dopamine and noradrenaline in post-mortem brain in Huntington's disease and schizophrenic illness.
    Bird ED; Spokes EG; Iversen LL
    Acta Psychiatr Scand Suppl; 1980; 280():63-73. PubMed ID: 6447433
    [No Abstract]   [Full Text] [Related]  

  • 2. Dopamine and homovanillic acid concentrations in the post-mortem brain in schizophrenia [proceedings].
    Bird ED; Crow TJ; Iversen LL; Longden A; Mackay AV; Riley GJ; Spokes EG
    J Physiol; 1979 Aug; 293():36P-37P. PubMed ID: 501607
    [No Abstract]   [Full Text] [Related]  

  • 3. Abnormal neuroleptic/dopamine receptors in schizophrenia.
    Lee T; Seeman P
    Adv Biochem Psychopharmacol; 1980; 21():435-42. PubMed ID: 6103653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea.
    Huot P; Lévesque M; Parent A
    Brain; 2007 Jan; 130(Pt 1):222-32. PubMed ID: 17142832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of dopamine D2-like receptors in postmortem CNS and pituitary: differential regional changes in schizophrenia.
    Dean B; Pavey G; Scarr E; Goeringer K; Copolov DL
    Life Sci; 2004 May; 74(25):3115-31. PubMed ID: 15081577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopaminergic abnormalities in postmortem schizophrenic brain.
    Mackay AV; Bird ED; Iversen LL; Spokes EG; Creese I; Snyder SH
    Adv Biochem Psychopharmacol; 1980; 24():325-33. PubMed ID: 7405668
    [No Abstract]   [Full Text] [Related]  

  • 7. Gamma-aminobutyric-acid deficiency in brain of schizophrenic patients.
    Perry TL; Kish SJ; Buchanan J; Hansen S
    Lancet; 1979 Feb; 1(8110):237-9. PubMed ID: 84898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased dopamine concentration in limbic areas of brain from patients dying with schizophrenia.
    Bird ED; Spokes EG; Iversen LL
    Brain; 1979 Jun; 102(2):347-60. PubMed ID: 455044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased brain dopamine and dopamine receptors in schizophrenia.
    Mackay AV; Iversen LL; Rossor M; Spokes E; Bird E; Arregui A; Creese I; Synder SH
    Arch Gen Psychiatry; 1982 Sep; 39(9):991-7. PubMed ID: 7115016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inverse relationship between brain noradrenaline level and dopamine loss in Parkinson disease: a possible neuroprotective role for noradrenaline.
    Tong J; Hornykiewicz O; Kish SJ
    Arch Neurol; 2006 Dec; 63(12):1724-8. PubMed ID: 17172611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased receptor-binding sites for kainic acid in brains of patients with Huntington's disease.
    London ED; Yamamura HI; Bird ED; Coyle JT
    Biol Psychiatry; 1981 Feb; 16(2):155-62. PubMed ID: 6452910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seasonal and circadian monoamine variations in human brains examined post mortem.
    Carlsson A; Svennerholm L; Winblad B
    Acta Psychiatr Scand Suppl; 1980; 280():75-85. PubMed ID: 6157305
    [No Abstract]   [Full Text] [Related]  

  • 13. Human brain levels of monoamines and their metabolites. Postmortem investigations.
    Gottfries CG
    Acta Psychiatr Scand Suppl; 1980; 280():49-61. PubMed ID: 6157304
    [No Abstract]   [Full Text] [Related]  

  • 14. Huntington's chorea. Post-mortem measurement of glutamic acid decarboxylase, choline acetyltransferase and dopamine in basal ganglia.
    Bird ED; Iversen LL
    Brain; 1974 Sep; 97(3):457-72. PubMed ID: 4157009
    [No Abstract]   [Full Text] [Related]  

  • 15. Monoamine transmitters and their metabolites in the basal ganglia of Huntington's disease and control postmortem brain.
    Walsh FX; Bird ED; Stevens TJ
    Adv Neurol; 1982; 35():165-9. PubMed ID: 6183949
    [No Abstract]   [Full Text] [Related]  

  • 16. Simultaneous gas chromatographic-mass spectrometric determination of dopamine, norsalsolinol and salsolinol enantiomers in brain samples of a large human collective.
    Musshoff F; Lachenmeier DW; Kroener L; Schmidt P; Dettmeyer R; Madea B
    Cell Mol Biol (Noisy-le-grand); 2003 Jul; 49(5):837-49. PubMed ID: 14528920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine and homovanillic acid concentrations in striatal and limbic regions of human brain.
    Walsh FX; Stevens TJ; Langlais PJ; Bird ED
    Ann Neurol; 1982 Jul; 12(1):52-5. PubMed ID: 7114818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of chronic "binge cocaine" on basal levels and cocaine-induced increases of dopamine in the caudate putamen and nucleus accumbens of C57BL/6J and 129/J mice.
    Zhang Y; Schlussman SD; Ho A; Kreek MJ
    Synapse; 2003 Dec; 50(3):191-9. PubMed ID: 14515336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Striatal dopamine and homovanillic acid in Huntington's disease.
    Reynolds GP; Garrett NJ
    J Neural Transm; 1986; 65(2):151-5. PubMed ID: 2939198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coupling of dopamine D1 recognition sites with adenylate cyclase in nuclei accumbens and caudatus of schizophrenics.
    Memo M; Kleinman JE; Hanbauer I
    Science; 1983 Sep; 221(4617):1304-7. PubMed ID: 6310753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.